Mayo Clinic Q & amp;A podcast: FDA sets stricter standards for COVID-19 vaccine development

In an effort to reassure the public about the safety and effectiveness of a vaccine, the Food and Drug Administration has set stricter standards for COVID-19 vaccine development. These standards include following phase 3 clinical trial participants for at least two months, and having at least five severe COVID-19 cases in the placebo group. The [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news